European Pharmaceutical Review

JUNE 26, 2024

In 2016, the company announced a new facility, the single largest life sciences investment in North Carolina at the time, Butch Lawter , Chair of the Johnston County Board of Commissioners, US, explained during a press conference. This is compared to the company’s $3.9 (DKK Completion is expected between 2027 and 2029.

Pharmaceutical Companies 104

Pharmaceutical Companies Pharmaceutical Companies 104

pharmaphorum

JUNE 23, 2025

Skip to main content Monday 23 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

59

59

European Pharmaceutical Review

AUGUST 9, 2023

While injectable biologic therapies are an effective option for CSU that is uncontrolled by these drugs, less than 20 percent of patients worldwide are treated with them, according to a 2016 British Journal of Dermatology paper and research shared by Novartis. There were 470 participants in the REMIX-1 study.

Immunization 94

Immunization Pharmaceutical Companies Pharmaceutical Companies 94

pharmaphorum

OCTOBER 20, 2020

The pandemic has triggered a change in how pharmaceutical companies are engaging with healthcare professionals. When IQVIA polled non COVID-19 treating Italian HCPs in March when the crisis was at its worst, it asked HCPs if they still welcomed pharmaceutical company engagement during the crisis. The answer was yes.

Pharmaceutical Companies 122

Pharmaceutical Companies Pharmaceutical Companies Documentation Communication 122

pharmaphorum

JUNE 17, 2025

billion takeover bid for Verve Therapeutics, upgrading a collaboration between the two companies that dates back to 2023. billion takeover bid for Verve Therapeutics, upgrading a collaboration between the two companies that dates back to 2023.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies FDA 59

pharmaphorum

JUNE 10, 2025

Skip to main content Tuesday 10 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies 85

Pharmaceutical Companies Pharmaceutical Companies FDA 85

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Pharmaceutical Companies 69

Pharmaceutical Companies Pharmaceutical Companies Packaging Insurance 69

Pharmaceutical Technology

JULY 12, 2022

In total, the frequency of sentences related to digitalization between July 2021 and June 2022 was 400% higher than in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings. of sentences in the company's filings.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Documentation 52

Pharmaceutical Technology

JUNE 28, 2022

In total, the frequency of sentences related to robotics between April 2021 and March 2022 was as frequent as in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings. Other top employers with high robotics mentions included Pfizer, Novartis and Sanofi.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Omnicell Documentation 52

Pharmaceutical Technology

AUGUST 9, 2022

In total, the frequency of sentences related to artificial intelligence between July 2021 and June 2022 was 400% higher than in 2016 when GlobalData, from whom our data for this article is taken, first began to track the key issues referred to in company filings. of sentences in the company's filings.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Documentation 52

Pharmaceutical Technology

JULY 5, 2022

Mentions of the future of work within the filings of companies in the pharmaceutical industry were 373% higher between April 2021 and March 2022 than in 2016, according to the latest analysis of data from GlobalData. Secondly, we calculated the percentage of total analysed sentences that referred to the future of work.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Documentation 52

pharmaphorum

JUNE 20, 2025

Skip to main content Friday 20 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

pharmaphorum

JUNE 8, 2021

The possibility of data being shared with third-parties including academic researchers and pharmaceutical companies – albeit pseudonymised – has raised concerns about whether the public is aware that they stand to lose control of private information on their physical, mental and sexual health. .”

Medical Records 98

Medical Records Pharmaceutical Companies Pharmaceutical Companies Communication 98

Pharma Marketing Network

DECEMBER 17, 2021

The wave of interest in sustainability follows the value chain from top-tier pharmaceutical companies to their suppliers of every size. About 80% of pharmaceutical companies have announced a commitment to becoming carbon-neutral or made a net-zero pledge for carbon emissions. Where do most organizations start?

Pharmaceutical Companies 103

Pharmaceutical Companies Pharmaceutical Companies Communication 103

Pharma Marketing Network

MAY 15, 2023

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered. Another challenge is the sheer volume of data that companies must manage.

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies 59

pharmaphorum

AUGUST 23, 2021

The possibility of data being shared with third-parties including academic researchers and pharmaceutical companies raised concerns about whether the public is aware that they stand to lose control of private information on their physical, mental and sexual health. Now that’s been set back indefinitely.

Medical Records 89

Medical Records Documentation Pharmaceutical Companies Pharmaceutical Companies 89

Pharmaceutical Technology

JUNE 29, 2022

A drug can also be considered for an orphan drug designation if a pharmaceutical company is unlikely to reclaim the research, development, and approval costs in addition to reasonable profit for a drug within seven years of an FDA approval.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies FDA 98

Pharmaceutical Technology

NOVEMBER 21, 2022

Based on GlobalData estimates, the Japanese pharmaceutical market generated JPY9.392 trillion ($67.32 However, despite this significant market share, the Japanese market is likely to become a less attractive market for international pharmaceutical companies based on recent findings from the Office of Pharmaceutical Industry Research (OPIR).

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Packaging Insurance 52

pharmaphorum

JUNE 16, 2025

Skip to main content Monday 16 June 2025 BlueSky linkedin youtube rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies 59

Pharmaceutical Companies Pharmaceutical Companies FDA 59

European Pharmaceutical Review

JULY 7, 2023

Despite a strong research base and an emerging data science sector targeting pharma R&D, the UK has not been successful in growing large UK biopharma companies. The sector is dominated by small and medium-sized enterprises (SMEs) that are frequently acquired by companies from the US or elsewhere before they scale-up.

Pharmaceutical Companies 104

Pharmaceutical Companies Pharmaceutical Companies Compounding 104

Pharma Marketing Network

MARCH 23, 2023

Big data has become an increasingly important tool for businesses across various industries, and the pharmaceutical industry is no exception. However, the use of big data in pharmaceutical marketing also poses significant challenges that must be considered. Another challenge is the sheer volume of data that companies must manage.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JULY 20, 2021

Allen is commercial director at EPG Health, which he joined in 2016. A bespoke and integrated toolset helps pharmaceutical companies to reach and engage target audiences with key educational messages while measuring the outcomes. About the interviewee. For more information visit www.epghealth.com.

Pharmaceutical Companies 105

Pharmaceutical Companies Pharmaceutical Companies 105

pharmaphorum

MARCH 16, 2021

The news comes as SpectronRx continues to scale its early-stage development and commercialization services for leading pharmaceutical companies working to develop and deploy radiopharmaceutical compounds for the treatment and detection of certain cancers and other diseases. facility at 9550 Zionsville Rd. in Indianapolis.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Compounding 52

European Pharmaceutical Review

OCTOBER 20, 2022

Annex 1 states that “at least one representative sample is included every day that the water is used for manufacturing processes” Another important aspect of grab sampling is the frequency, which is up to the pharmaceutical company to determine. Chemie Ingenieur Technik , 2016, Årg. Minnish C, Hardy S, Krämer S.

Pharmaceutical Companies 98

Pharmaceutical Companies Pharmaceutical Companies FDA 98

European Pharmaceutical Review

SEPTEMBER 25, 2023

Gregory’s industrial career spans an employment history with several major pharmaceutical companies. 2016; 37(3): 117–24. 2016; 408(21): 5915–24. Chromatography. Jaccoulet E, Boccard J, Taverna M, et al. Anal Bioanal Chem. Prullière F.,

Compounding 98

Compounding Pharmaceutical Companies Pharmaceutical Companies FDA 98

European Pharmaceutical Review

JULY 4, 2024

2 It was first approved as Fulyzaq in December 2012 and in October 2016, Napo Pharmaceuticals launched the new brand, Mytesi. She specialises in regulatory compliance and assists medical device, biotech and pharmaceutical companies as well as food & beverage companies with meeting their UK and EU regulatory obligations.

FDA 103

FDA Documentation Pharmaceutical Companies Pharmaceutical Companies 103

Roots Analysis

MARCH 26, 2024

However, the road for transition from the conventional batch to continuous manufacturing requires a shift in variety of parameters and is still quite unclear to many of the pharmaceutical companies. Whereas, two drugs received the PMDA approval, namely TRAMACET by Johnson and Johnson and VERZENIO® by Eli Lilly.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies FDA 52

Birth Control Pharmacist

APRIL 18, 2023

The next step is having a pharmaceutical company manufacture a product that can be FDA-approved for OTC use. HRA Pharma , a French pharmaceutical company acquired by Perrigo, is working with Ibis Reproductive Health to bring the product Opill to the US market. Oral contraception checks all of these boxes. What is Opill?

FDA 52

FDA Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

AUGUST 17, 2020

As the public becomes increasingly comfortable with exchanging a measure of personal data for more personalised communications, financial companies have been able to build trust and engage potential customers at key decision-making points in their journey with content that really resonates with them.

Communication 97

Communication Insurance Packaging Pharmaceutical Companies 97

PharmaShots

MAY 15, 2023

Allyson Moellenhoff: Kalderos was founded in 2016 by Jeremy Docken, our chief strategy officer. One of those product suites is Kalderos for Manufacturers, a web-based suite of tools for pharmaceutical companies that sits on top of the Drug Discount Management platform. And that hurts all patients down the road.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Hospitals 40

PQA

SEPTEMBER 19, 2024

I joined AMCP in February 2016, but before that, I had spent much of my career in health care associations. When I came to AMCP in 2016, I was thrilled because it was a crucial time with a new administration being elected. In this Q&A, she shares with us her background, experience and insights on PQA’s work.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Patient Care 40

ISPE

MARCH 7, 2023

A collaborative mindset must prevail between pharmaceutical companies, suppliers, and regulators and include strategic partnerships that go beyond the pharmaceutical sector so we can move together to a more sustainable future. The risks are equally applicable to both privately owned and publicly traded companies.

Health and Personal Care Stores 52

Health and Personal Care Stores Pharmaceutical Companies Pharmaceutical Companies Communication 52

ISPE

MAY 9, 2023

In an era when the world is accelerating the development of drugs and targeted medicines using innovative technologies, pharmaceutical companies still face registration hurdles for well-characterized molecules because of redundant or additional local regulatory requirements. Published 29 February 2016. Position paper.

Documentation 52

Documentation Packaging Pharmaceutical Companies Pharmaceutical Companies 52

pharmaphorum

JUNE 11, 2025

Skip to main content Wednesday 11 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Pharmaceutical Companies 87

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 87

pharmaphorum

JUNE 6, 2025

Skip to main content Friday 6 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views & (..)

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Vaccines FDA 52

pharmaphorum

JUNE 11, 2025

Skip to main content Wednesday 11 June 2025 twitter linkedin facebook rss User account menu Subscribe Channels Channels Digital Market Access Oncology Patients R&D Sales & Marketing Spotlight on Content type Content type Digital -News -Views & Analysis -Deep Dive -Webinars -Podcasts -Video -White Papers -Event Market Access -News -Views (..)

Pharmaceutical Companies 91

Pharmaceutical Companies Pharmaceutical Companies FDA 91

The Checkup by Singlecare

MARCH 8, 2024

It was FDA approved in 2016 and became available in the United States in January 2023. The pharmaceutical company that makes Amjevita is called Amgen, Inc. The pharmaceutical company that makes Cyltezo is called Boehringer Ingelheim Pharmaceuticals, Inc. Cyltezo is citrate-free.

Dosage 97

Dosage Pharmaceutical Companies Pharmaceutical Companies FDA 97